E

Emergent Biosolutions
D

EBS

6.99500
USD
-0.10
(-1.34%)
مغلق
حجم التداول
27,234
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
379,673,400
أصول ذات صلة
CBOE
CBOE
-1.700
(-0.73%)
229.800 USD
CME
CME
1.01
(0.37%)
276.84 USD
FDS
FDS
0.09
(0.02%)
448.00 USD
ICE
ICE
1.730
(0.95%)
183.380 USD
MMC
MMC
3.690
(1.74%)
216.360 USD
MSCI
MSCI
-2.86
(-0.49%)
580.01 USD
NDAQ
NDAQ
0.490
(0.55%)
90.010 USD
TRV
TRV
6.69
(2.60%)
264.12 USD
المزيد
الأخبار المقالات

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segmentwhich consists of NARCAN and other commercial products.